MedTrace Logo

Reconstitution of HIV-specific Immunity Against HIV

NCT02563509 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-06-06

No results posted yet for this study

Summary

Research Goal: To reconstitute the anti-HIV specific immunity system of the AIDS patients, so the viruses could not massively replicate when HAART was discontinued, then make HIV functional cure possible.

Conditions

Interventions

BIOLOGICAL

HIV-specific CD8 cells

Based on HAART, receive HIV-specific CD8 cells transfuion.

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Guangzhou 8th People's Hospital

    lead OTHER

Principal Investigators

  • Hui Zhang, doctor · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02563509 on ClinicalTrials.gov